Top Biotechnology companies in Switzerland by Net Cash Used For Investing Activities
Switzerland
# |
Name |
Net Cash Used For Investing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 5.60 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
| 2 |
USD 374.65 M
|
Dec. 31, 2023 | USD 38.36 | -1.26% |
|
Switzerland |
|
| 3 |
USD 77.97 M
|
Dec. 31, 2023 | USD 2.61 | NA |
|
Switzerland |
|
| 4 |
USD 53.02 M
|
Dec. 31, 2023 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 5 |
USD 0.00
|
Dec. 31, 2023 | USD 2.03 | -1.93% |
|
Switzerland |
|
| 6 |
USD -8.13 K
|
Dec. 31, 2023 | USD 7.39 | -3.40% |
|
Switzerland |
|
| 7 |
USD -387.20 K
|
Dec. 31, 2023 | USD 24.15 | -4.07% |
|
Switzerland |
|
| 8 |
USD -1.23 M
|
Dec. 31, 2023 | USD 44.53 | -0.85% |
|
Switzerland |
|
| 9 |
USD -3.22 M
|
Dec. 31, 2023 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 10 |
USD -19.49 M
|
Dec. 31, 2023 | USD 1.16 K | 0.97% |
|
Switzerland |
|
| 11 |
USD -25.18 M
|
Dec. 31, 2023 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 12 |
USD -64.39 M
|
Dec. 31, 2023 | USD 22.44 | 0.27% |
|
Switzerland |
|
| 13 |
USD -65.69 M
|
Dec. 31, 2023 | USD 27.99 | -3.47% |
|
Switzerland |
|
| 14 |
USD -100.05 M
|
Dec. 31, 2023 | USD 244.50 | 0.95% |
|
Switzerland |
|
| 15 |
USD -166.40 M
|
March 31, 2024 | USD 229.49 | 0.50% |
|
Switzerland |
|
| 16 |
USD -174.44 M
|
Dec. 31, 2023 | USD 1.04 K | -2.38% |
|
Switzerland |
|
| 17 |
USD -199.45 M
|
Dec. 31, 2023 | USD 2.41 | 0.50% |
|
Switzerland |
|
| 18 |
USD -202.87 M
|
Dec. 31, 2023 | USD 61.01 | 0.32% |
|
Switzerland |
|
| 19 |
USD -216.24 M
|
March 31, 2024 | USD 355.46 | -1.48% |
|
Switzerland |
|
| 20 |
USD -551.77 M
|
Dec. 31, 2023 | USD 42.16 | 0.08% |
|
Switzerland |
|
| 21 |
USD -877.48 M
|
Dec. 31, 2023 | USD 97.52 | 0.29% |
|
Switzerland |
|
| 22 |
USD -1.30 B
|
Dec. 31, 2023 | USD 588.68 | -0.80% |
|
Switzerland |
Frequently Asked Questions
-
Which Biotechnology company in Switzerland has the highest Net Cash Used For Investing Activities ?
The Biotechnology company in Switzerland with the highest Net Cash Used For Investing Activities is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 5.60 B.
-
Which Biotechnology company in Switzerland has the lowest Net Cash Used For Investing Activities ?
The Biotechnology company in Switzerland with the lowest Net Cash Used For Investing Activities is Lonza Group AG (Swiss Stock Exchange: LONN.SW) at USD -1.30 B.
-
What are the top 10 Biotechnology companies in Switzerland by Net Cash Used For Investing Activities ?
The top 10 Biotechnology companies in Switzerland by Net Cash Used For Investing Activities are Novartis AG, CRISPR Therapeutics AG, AC Immune SA, Molecular Partners AG, NLS Pharmaceutics AG, Addex Therapeutics Ltd, Kuros Biosciences AG, Basilea Pharmaceutica AG, ADC Therapeutics SA and Metall Zug AG.
-
What are the bottom 10 Biotechnology companies in Switzerland by Net Cash Used For Investing Activities ?
The bottom 10 Biotechnology companies in Switzerland by Net Cash Used For Investing Activities are Lonza Group AG, DSM-Firmenich AG, Sandoz Group AG, Ypsomed Holding AG, Bachem Holding AG, Meyer Burger Technology AG, Siegfried Holding AG, Dottikon Es Holding AG, Tecan Group AG and PolyPeptide Group AG.